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Abstract
Background: Over the past decade, cardiovascular diseases (CVDs) have been the leading cause of death in the
world. Ischemic heart diseases (IHDs) are the main form of CVDs and are the most important single cause of death
around the world. This study aimed to estimate the burden of IHDs in the city of Isfahan by calculating
disability-adjusted life years (DALYs).
Methods: This population-based study was conducted on the population living in the city of Isfahan in 2014.
Years of life lost due to premature mortality (YLLs) were calculated by multiplying the number of deaths due
to IHDs (that was collected from death registration system (DRS) and was adjusted for incompleteness and
misclassification) with life expectancy (that was extracted from the Global Burden of Diseases, Injuries, and
Risk Factors study (GBD) 2013). Years lived with disability (YLDs) were calculated by multiplying the prevalent
cases of IHDs in each age-sex group (that was calculated using the stepwise approach to non-communicable
disease risk factor surveillance (STEPS)) with total disability weight of IHDs (that was calculated using the GBD
2013). DALYs were calculated as the sum of YLDs and YLLs.
Results: In 2014, the number of DALYs due to IHDs was 43517.71 years which was formed of 31891.79 years
of YLLs and 11625.92 years of YLDs. The rate of DALYs due to IHDs was 4412.33 (95% uncertainty interval (UI): 3636.70–
5162.72) person-years per 100,000 persons in males and 3476.66 (95% UI: 2948.95–4010.51) person-years per 100,000
persons in females. The highest rates of YLLs, YLDs, and DALYs due to IHDs in both sexes were occurred in 80 years
and older.
Conclusions: The highest proportion of the burden of IHDs in the city of Isfahan was attributed to YLLs in the elderly
people. Since the majority of the population of Isfahan is <60 years old and IHDs are long-lasting, the health authorities
are recommended to design and implement educational and cultural programs to inform people about the risk factors
and the methods to prevent these diseases. These programs can be used as a strategy to reduce the incidence of IHDs
from an early age.
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Background
Mortality indicators alone do not properly reflect the
health status of a population. Therefore, the health status
of communities is assessed by the summary measures of
population health (SMPH) that utilizes a combination of
data on mortality and non-fatal consequences of diseases
and injuries to express a population’s health status in
quantitative form. One of these measures is disability-
adjusted life years (DALYs) that indicate the years of life
either lost due to premature death or lost as a result of
disability caused by non-fatal diseases. The Global Burden
of Disease study (GBD) uses this indicator for the calcula-
tion of burden of diseases [1].
In the past decade, cardiovascular diseases (CVDs)
have been the leading cause of death all over the world
[2]. In 2015, CVDs accounted for nearly 17.9 million
deaths (32.12% of all deaths) and almost 347.5 million
DALYs (14.12% of the total DALYs) in the world [3]. Is-
chemic heart diseases (IHDs) are the main form of
CVDs which lead to 7.2 million deaths each year, most
of which occur in developing countries [4]. In 2013,
IHDs led to 8.1 million deaths in the world (14.8% of
total deaths and almost 50% of deaths due to CVDs) [5];
and in 2015 they accounted for almost 164million
DALYs (6.70% of the total DALYs and almost 47.19% of
DALYs due to CVDs) in the world. According to the
GBD 2015, CVDs were the cause of 20.23% of the total
burden of diseases in Iran, of which 10.95% were related
to IHDs (the leading cause of the total burden of dis-
eases). In addition, IHDs were the leading cause of death
(with 25.82% of all deaths) in 2015 in Iran [3]. In 2014,
46% of all deaths were reported to be due to CVDs in
Iran [6]. In 2011, 43.92% of all deaths are caused by
CVDs in Isfahan province [7].
To make the right decision about health priority, it is
necessary to have some measures such as DALYs [8].
Also, Sub-national studies with more data on provincial
and even city data to estimate the burden of IHDs can
help to provide objective evidence and to access appro-
priate and detailed fundamental data which health policy
makers need to make health policies, and design and
manage appropriate interventions [9].
Since there is not already published information on
the burden of IHDs at the sub-national level in Iran, the
present study was designed and implemented in order to
estimate the burden of IHDs in the city of Isfahan, which
is the second largest city in Iran and located in the
center of this country.
Methods
This population-based study was conducted in the city
of Isfahan in 2014. The study population was calculated
by a demographic projection model, called DemProj,
which uses the cohort-component method for making
population projection [10]. This method has been de-
scribed in detail elsewhere [11]. The inputs were the
population in the base year (census 2011), the total fer-
tility rate (1.7) that was collected from Isfahan University
of Medical Sciences, the sex ratio at birth (102) that was
collected from statistical center of Iran, and the life ex-
pectancy at birth (73 and 77 years for males and females,
respectively) that were collected from NCDRC, Tehran
University of Medical Sciences. Also, life table (Coale-
Demeny West model) and age- specific fertility rate (aver-
age model table) were selected as options in DemProj.
The burden of IHDs was estimated by calculating
DALYs which is formed of two component including
years of life lost due to premature mortality (YLLs) and
years lived with disability (YLDs) [12]. The scientific
scheme of the processes of this study is plotted in Fig. 1.
Calculating YLLs
In order to calculate YLLs, we need to have two compo-
nents: 1) the number of deaths due to IHDs that ad-
justed for incompleteness and misclassification by sex
and age (N); 2) life expectancy by sex and age (L). To
determine the first component, the four following steps
were taken:
In the first step, it was tried to calculate the incom-
pleteness of mortality data among children less than
5 years old and people aged 5 years and older. The first
was not calculated because deaths due to IHDs in this
age group are not common and in the present study
there was not any death due to IHDs in this age group.
The latter was calculated through the following stages:
a) collecting the population data of two censuses (2006
and 2011); b) collecting mortality data in 2006–2011
that registered based on international statistical classifi-
cation of diseases and related health problems (ICD-10)
codes [13] (that were set in according to the epidemio-
logical conditions in Iran) in Bagh-e-Rezvan cemetery in
Isfahan; c) cleaning mortality data; d) selecting the cases
of deaths between the two censuses; e) imputing un-
known ages (using linear regression model); f ) estimat-
ing the percentage of completeness of death registration
system (DRS) using death distribution methods (general-
ized growth balance (GGB), synthetic extinct generations
(SEG), and a hybrid of the two methods separately); and
g) calculating the final percentage of completeness of
DRS (the mean of completeness resulted from three
death distribution methods) in Isfahan in 2011 as an al-
ternative for the final percentage of completeness of
DRS in 2014 [14–17].
In the second step, the following stages were per-
formed to adjust misclassification: a) collecting mortality
data in 2014 that registered based on ICD-10 codes in
Bagh-e-Rezvan cemetery in Isfahan; b) cleaning mortality
data; c) imputing unknown ages (using linear regression
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model); d) imputing the causes of death without any
ICD-10 code, causes of death that were coded as R00-
R99 (ill-defined codes), DxC-DxD (cancer without de-
tails), F70-F79 (mental retardation), and impossible and
improbable age codes with the correct ones (using
multinomial logistic regression); e) exchanging impos-
sible and improbable sex codes with the correct ones
(by reviewing the name of the deceased persons); f ) col-
lapsing mortality data by age, sex, and cause of death;
g) redistributing garbage codes that are including A40-
A41 (septicemia), I26 (pulmonary embolism), I50 (heart
failure), I74 (arterial embolism and thrombosis), and
N17 (Acute kidney failure) among equivalent correct
ICD-10 codes in every age and sex group (proportional
to size according to number of deaths); and h) calculat-
ing the percentage of deaths due to IHDs among people
aged 5 years and older by age and sex in 2014.
In the third step, the total number of adjusted
deaths for incompleteness among people aged 5 years
and older by age and sex in 2014 was calculated through
the equation [14]
total number of adjusted deaths f or incompleteness
¼ total number of deaths in 2014
final percentage of completeness of DRS in 2011
In the fourth step, the number of deaths due to IHDs
by age and sex in 2014 which adjusted for incomplete-
ness and misclassification (N) was calculated through
the equation
N ¼ total number of deaths in 2014
final percentage of completeness of DRS in 2011
 
 percentage of deaths due to IHDs in 2014
Uncertainty intervals (UI) for N was calculated through
the equation
Fig. 1 Scientific scheme of the processes, data sources and estimation of Burden of ischemic heart diseases
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N lower boundary ; upper boundaryð Þ
¼ total number of deaths in 2014
final percentage of completeness of DRS in 2011 0:19
 
percentage of deaths due to IHDs in 2014
; Where 0.19 is the standard deviation of the final per-
centage of completeness of DRS that is equal to 20% of
the final percentage of completeness of DRS [16].
To determine the second component of YLLs i.e. life
expectancy (L), we used the standard abridged life table
which had been used in the GBD 2010 and GBD 2013 [17].
Finally, we used the equation YLLs =N × L to calculate
YLLs due to IHDs.
UI for YLLs was calculated through multiplying the
lower and upper boundaries of N by L.
Calculating YLDs
We need to have the number of prevalent cases (P) and
disability weight (DW) of IHDs, in order to calculate
YLDs. The number of prevalent cases were calculated
using the stepwise approach to non-communicable dis-
ease risk factor surveillance (STEPS) study that was con-
ducted in Isfahan province in 2011 [18]. The STEPS
study methodology has been described elsewhere [19].
In this study, we calculated total disability weight of
IHDs as follows: a) the number of every sequela of IHDs
and its subsets plus disability weights of subsets were ex-
tracted from the GBD 2013; b) the percentage of subsets
of every sequela of IHDs in 2013 was calculated by div-
iding the number of every subset by the number of every
sequela; c) the percentage of every sequela of IHDs in
2013 was calculated by dividing the number of every se-
quela of IHDs by the total number of all sequelae of IHDs;
d) disability weight of every sequela of IHDs in 2013 was
calculated by multiplying the percentage of every subset of
every sequela of IHDs by disability weight of that subset
and then, summing up all the subsets; e) total disability
weight of IHDs in 2013 in the world was calculated by
multiplying the percentage of every sequela of IHDs by
disability weight of the same sequela, and then, summing
up all the sequelae of IHDs.
Then, YLDs due to IHDs were calculated through the
equation YLDs = P ×DW; Where P is the number of
prevalent cases of IHDs in each age-sex group, DW is
total disability weight of IHDs in GBD 2013.
UI for the number of YLDs was calculated through the
equation
YLDs(lower boundary , upper boundary) = (P ± SE(P) × 1.96) ×
DW; Where SE(p) is the standard error of the number of
prevalent cases that were calculated using the STEPS study.
While estimating the burden of diseases using statis-
tical models, two types of uncertainty may occur: uncer-
tainty arising from sampling (sample uncertainty) and
uncertainty resulting from the use of statistical models
(model uncertainty) [15]. In order to calculate “sample
uncertainty” related to the number of YLLs and YLDs
we used a simulation model to take 1000 draws from the
number of YLLs and YLDs for each age, sex and then the
95% UI was calculated as the 2.5th and 97.5th percentiles
of the 1000 draws. In this study, because there were not
proper computing facilities, “model uncertainty” of the
number of YLLs and YLDs were not determined.
Calculating DALYs
Finally, DALYs due to IHDs in Isfahan in 2014 was cal-
culated through the equation DALYs = YLLs + YLDs in
each age-sex group.
Data analysis was performed using STATA software
version 12.0 (Stata Corp, College Station, TX, USA), R stat-
istical software version 3.1.0 (R Foundation for Statistical
Computing, Vienna, Austria), Spectrum software version
5.03 (Avenir Health, Washington, USA), and Excel 2010
software (Microsoft Corp, Redmond, Washington, USA).
Results
In 2014, Isfahan city population (in age groups that were
used in this study) was estimated to be 1,100,793 people,
of whom 560,764 (50.94%) were males and 540,029
(49.06%) were females (Table 1).
The percentage of completeness of DRS which was
estimated using GGB, SEG, and hybrid methods respect-
ively, were 92%, 100%, and 92%. The mean of complete-
ness resulted from three death distribution methods was
95% which was considered as the final percentage of
completeness of DRS in Isfahan in 2011. Thus the final
percentage of incompleteness was 5%.
The number of registered deaths in Bagh-e-Rezvan
cemetery during the year 2014 was 4741 which was
changed to 4625 after data cleaning. Moreover, 498 ICD-
10 codes were imputed, of which 257 deaths were with-
out ICD-10 code, 205 deaths were coded as R00-R99, 33
deaths were coded as DxC-DxD, two deaths were coded
as F70-F79, and one death was coded as impossible and
improbable age death. On the other hand, there was only
one impossible and improbable sex code that was cor-
rected via reviewing the name of the deceased person. In
total, there were five garbage codes (including A40-A41,
I26, I50, I74, and N17) which included a total of 828
people; they were redistributed among the correct ICD-
10 codes of the same age-sex group.
After redistribution, 36.7% of deaths were attributed to
IHDs and the number of simulated deaths due to IHDs
was 1719, of which 967 (56.3%) occurred among males
and 752 (43.7%) occurred among females. The highest
numbers of deaths were observed among males and fe-
males aged 80 years and older (372 and 401, respect-
ively) and the lowest numbers of deaths were observed
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among males and females aged 25–29 years old (two
and two, respectively) (Table 1).
The highest and lowest prevalent cases of IHDs in
males were observed in 25–29 years old and 80 years
and older people, respectively, while in females, 55–59
and 25–29 years old people had the highest and lowest
prevalent cases of IHDs (Table 2).
The numbers (rates) of DALYs due to IHDs were
24742.74 (95% UI: 20393.29–28950.69) years (4412.33
(95% UI: 3636.70–5162.72) person-years per 100,000
persons) in males and 18774.97 (95% UI: 15925.19–
21657.92) years (3476.66 (95% UI: 2948.95–4010.51)
person-years per 100,000 persons) in females. In
addition, the number (rate) of DALYs was 43517.71
(95% UI: 38212.10–48778.92) years (3953.31 (95% UI:
3471.33–4431.25) person-years per 100,000 persons) in
both sexes. The highest and lowest numbers and rates of
DALYs in males were observed in 80 years and older
and 40–44 years old people, respectively. The highest and
lowest numbers and rates of DALYs in females were ob-
served in 80 years and older and 25–29 years old people,
respectively. The highest and lowest numbers of DALYs in
both sexes were observed in 80 years and older and 40–44
years old people, respectively; moreover, the highest and
Table 1 The number of adjusted deaths due to ischemic heart diseases after redistribution by age, sex
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25–29 113083 23 24.21 23.22 2.11 9.09 2.20 61.40
30–34 84388 25 26.32 23.22 2.11 9.09 2.39 54.46
35–39 68341 38 40.00 33.77 4.82 14.27 5.71 51.53
40–44 64163 32 33.68 33.78 5.28 15.63 5.26 46.64
45–49 55959 41 43.16 41.15 9.04 21.97 9.48 41.80
50–54 46931 55 57.89 52.74 13.41 25.43 14.72 37.05
55–59 34669 81 85.26 83.30 21.65 25.99 22.16 32.38
60–64 23496 116 122.11 119.08 43.61 36.62 44.72 27.81
65–69 17314 152 160.00 140.01 58.61 41.86 66.98 23.29
70–74 12898 166 174.74 161.80 56.68 35.03 61.21 18.93
75–79 10025 231 243.16 214.54 101.57 47.34 115.11 14.80
> =80 8762 870 915.79 883.78 387.64 43.86 401.67 10.99
total 540029 1830 1926.32 1810.39 706.53 39.03 751.61 -
Male
25–29 111437 58 61.05 58.19 1.56 2.68 1.64 61.40
30–34 86075 83 87.37 82.09 7.27 8.86 7.74 54.46
35–39 71916 62 65.26 67.49 4.43 6.56 4.28 51.53
40–44 67554 73 76.84 75.82 9.35 12.33 9.47 46.64
45–49 58635 92 96.84 95.57 28.81 30.15 29.20 41.80
50–54 49678 150 157.89 152.65 46.77 30.64 48.38 37.05
55–59 37826 207 217.89 193.16 69.33 35.89 78.20 32.38
60–64 25616 213 224.21 211.54 70.27 33.22 74.48 27.81
65–69 19142 249 262.11 236.33 92.14 38.99 102.20 23.29
70–74 14556 259 272.63 259.79 118.91 45.77 124.78 18.93
75–79 10396 302 317.89 313.83 116.79 37.21 118.29 14.80
> =80 7933 869 914.74 895.87 361.23 40.32 368.82 10.99
total 560764 2617 2754.72 2642.33 926.86 35.08 967.48 -
Total 1100793 4447 4681.04 4452.72 1633.39 36.68 1719.09 -
aThe final percentage of completeness of death registration system in 2011 that obtained from death distribution methods
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lowest rates of DALYs in both sexes were observed in
80 years and older and 25–29 years old people, respect-
ively. The number of DALYs were in high proportion at
adults <60 years old (45.29% of the number of DALYs lost
in males <60 years old and 34.79% of the number of
DALYs lost in females <60 years old). The number of
YLLs and YLDs were accounted for roughly 73% and 27%
of the total number of DALYs due to IHDs in both sexes,
respectively. Also, 52.15% of the total number of DALYs
due to IHDs in both sexes was attributed to YLLs in eld-
erly (>60 years old) people. The highest rates of YLLs and
YLDs due to IHDs in both sexes were occurred in 80 years
and older and the lowest rates of YLLs and YLDs due to
IHDs in both sexes were occurred in 25–29 years old and
40–44 years old people, respectively (Table 3).
The rates of DALYs were increased with increasing the
age in both sexes and were higher in males than in fe-
males in all age groups, except in 30–34, 40–44, 75–79
years old people, and 80 years and older (Fig. 2).
Total disability weight of IHDs that was calculated
using data from GBD 2013 and used in this study was
0.104 (Table 4).
Discussion
Based on our findings, the rates of DALYs due to IHDs
in the city of Isfahan in 2014 were increased in males
and females with increasing age and the highest rate of
burden of IHDs was seen in the elderly people. Also,
IHDs were the leading cause of death in the city of
Isfahan in 2014. This finding is consistent with the re-
sults of the GBD 2015 in the world and Iran [3] and
other studies [20, 21].
In this study, notable gender differences were observed
for the total numbers and rates of YLLs and DALYs
due to IHDs, for which the total numbers and rates of
YLLs and DALYs were higher in males than females.
The same results have been observed in other studies
[3, 5, 9, 22]. For the Probable reason, females may be
more sensitive to health knowledge, having better
behavior to seek health care and having better access
to primary prevention [23].
In addition based on the findings of the present study,
about one-half of the number of DALYs due to IHDs in
males and one-third of the number of DALYs due to
IHDs in females were occurred in <60 years old. Also,
the percentage of the population in males and females
<60 years old were 86.15% and 86.57% respectively.
These results show that the burden of IHDs was more
in people who known as productive persons and it will
affect national economies [24] and also emphasize the
importance of primary preventive measures for CVDs
even in the younger people. By accepting the increase in
the burden of IHDs with increasing age, primary pre-
ventive measures supplemented with secondary and ter-
tiary prevention measures should be adapted to each
population group and maintained up to older ages [25].
In 2014, Moran et al. indicated that in the North Africa/
Middle East and South Asia regions—regions with high
IHDs burden— about one-third (29%) of the number of
DALYs in males and a quarter (24%) of the number of
DALYs in females <50 years old were due to IHDs [24].
Also, GBD 2015 showed that IHDs are the leading
cause of burden of diseases in the Middle East and
North African countries [3]. The high burden of IHDs in
Table 2 The number of prevalent cases of ischemic heart diseases by age, sex in Isfahan city, 2014
Prevalent cases of IHDs
[95% UI]
Age Male Female
25–29 10140.77 [8879.98–11401.55] 2940.16 [2366.10–3514.21]
30–34 5250.58 [4251.83–6249.32] 8185.64 [7110.53–9260.74]
35–39 6975.85 [6133.16–7818.54] 3963.78 [3283.44–4644.12]
40–44 1486.19 [1188.27–1784.10] 3978.11 [3222.29–4733.92]
45–49 6039.41 [5328.66–6750.15] 3861.17 [3261.22–4461.12]
50–54 8693.65 [7792.01–9595.29] 7978.27 [7223.99–8732.55]
55–59 4463.47 [4027.53–4899.41] 8216.55 [7638.97–8794.14]
60–64 3714.32 [3372.91–4055.73] 6061.97 [5729.47–6394.46]
65–69 1091.09 [884.37–1297.82] 4155.36 [3901.86–4408.86]
70–74 1732.16 [1541.03–1923.30] 3753.32 [3528.62–3978.02]
75–79 1268.31 [1129.70–1406.92] 3248.10 [3062.76–3433.44]
> =80 1023.36 [913.58–1133.13] 3566.13 [3380.78–3751.49]
total 61684.04 [54649.01–68719.07] 105305.66 [97568.12–113043.19]
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these countries is probably attributed to several factors
such as increasing of the prevalence of risk factors, lim-
ited access to health care services in both prevention
and treatment of IHDs. Thus, these countries may need
to emphasize health promotion and disease prevention,
control of modifiable risk factors, and treatment of
acute and chronic medical conditions to reduce the
burden of IHDs [26].
The present study showed that the total numbers and
rates of YLDs due to IHDs were lower in males than fe-
males. It is probably due to the lower prevalent cases of
IHDs in males. These results are inconsistent with the
results of the GBD 2015 in the world and Iran [3] and
another study [9]. This inconsistency might be due to
the differences between our study and other studies in
terms of the sources of data and methods that we used
to estimate the prevalent cases and disability weights.
Estimations of the prevalent cases in the GBD 2010 and
GBD 2013 were carried out based on a systematic review
and then using Bayesian meta-regression method [12],
while, we used the data that were collected by STEPS
study in the present study.
Fig. 2 Disability-adjusted life years due to ischemic heart diseases by age and sex in Isfahan city, 2014
Table 4 Calculation of total disability weight of ischemic heart diseases in the world in 2013 [29]
Number of every sequela
and its subsets (thousands-
GBD 2013)
Disability weight











Ischemic heart diseases - - - - - 0.104
AMI SEQUELA - - - 0.01 0.099 -
Acute myocardial infarction
(First 2 days)
29.70 0.432 7% - - -
Acute myocardial infarction
(3 to 28 days)
385.90 0.074 93% - - -
ANGINA SEQUELA - - - 0.99 0.104 -
Mild 13157.00 0.033 35% - - -
Moderate 6914.00 0.08 18% - - -
Severe 17945.60 0.167 47% - - -
total 38432.20 - - - - -
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It is worth to mention that the data which is from
GBD studies are representative at the national level.
Having the distribution of diseases at the sub-national
level would be a clue for performing the interventions
that reduce or control main health problems among
sub-national populations [27]. Thus, it is recommended
to conduct further studies to estimate the burden of
diseases at subnational levels to prioritize health issues.
The strengths of this study are the adjustment of
incompleteness and misclassification of mortality data,
calculation of “sample uncertainty” and thus, reducing the
measurement error, and use of the data that collected by
the STEPS study to estimate the prevalent cases of IHDs.
This study has several limitations. Firstly, since the
DRS did not provide the data on every type of IHDs sep-
arately, it was not possible to estimate the burden of
every type of IHDs separately. Secondly, the validity of
our findings may be affected by the quality of death cer-
tificates which are subject to information bias probably
due to differences in physicians’ education programs and
also their training in completing death certificates [28].
Thirdly, in order to calculate the incompleteness of mor-
tality data in DRS on 5 years old and above people, we
had to calculate the incompleteness of mortality data in
2011 and used it as an alternative for the year 2014.
Fourthly, it was not possible to calculate directly the
prevalent cases of IHDs since the mild cases of IHDs
(who had not been hospitalized) were not registered. In
addition, the cases that referred to hospitals in other cities
and districts were possibly not registered as well. As a re-
sult, the prevalent cases of these diseases were estimated
using data from the STEPS study. Fifthly, because of the
lack of data for all sequelae we did not consider comorbid-
ity in the calculation of disability weight in this study. Fi-
nally, because there were not proper computing facilities,
we could not calculate “model uncertainty”.
Conclusions
The results of this study showed that the highest propor-
tion of burden of IHDs in the city of Isfahan was attrib-
uted to YLLs in the elderly people. Since the majority of
the population of Isfahan is <60 years old and IHDs are
long-lasting, the health authorities are recommended to
design and implement educational and cultural programs
to inform people about the risk factors and the methods to
prevent these diseases. These programs can be used as a
strategy to reduce the incidence of these diseases from an
early age. Accordingly, it is recommended to train physi-
cians about the correct methods of completing death
certificates to reduce information bias in the data, and con-
duct further similar researches in other cities after the
2016 census to achieve a more accurate estimate on the in-
completeness of mortality data among people aged over
5 years, and estimate “model uncertainty” in future studies.
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